Hi there
I am looking for a list of GlaxoSmithKlines global manufacturing
facilities/plants. I just completed a list for Genzyme and the answer
would look like this

USA
San Carlos	CA	Diagnostic test kits and reagents

If the product manufactured can be determined that would be a plus, if
not, not to worry.

Thanks

Hello Gill,

This is a complex one!  GSK sometimes has more than one subsidiary
operating out of one location. For example, Stockley Park is
identified as a production location for Glaxo Operations UK Ltd and
also for Glaxo Wellcome UK Ltd.  It is not clear whether they count
this as one unit or two. Also, the company reports, as available on
the GSK web site, list only the principal subsidiary undertakings and
only the headquarters.  For example, production in Turkey is listed
under Istanbul, but in fact the actual plant is in Gebze.  At least
this does indicate that production takes place in that country.
However, the whole sitution is very labile, because effects of the
merger are still having an influence, and a number of plants have been
or will be shut down.

I’ve hesitated for some time about whether to post this as an answer
or not, because it does not answer your query fully.  However, I do
believe that this is as accurate and detailed a list as it is possible
to obtain from public sources.

ARGENTINA
Munro – pharmaceuticals 
San Fernando - pharmaceuticals

AUSTRALIA
Boronia, Victoria – prescription medicines
Port Fairy, Victoria – extraction of opiates from poppies
Ermington, New South Wales - consumer healthcare

BANGLADESH
Chittagong – penicillin

BELGIUM
Wavre-Nord – vaccines
Rixensart – vaccines
Genval – pharmaceuticals, consumer healthcare

BRAZIL
Jacarepagua, near Rio de Janeiro – pharmaceuticals, inc non-CFC
products
Bahia - pharmaceuticals

CANADA
Missisauga – pharmaceuticals

CHINA
Chongqing – pharmaceuticals
Suzhou – pharmaceuticals, inc. anti-infective drugs and antibiotics
(there was a brief allusion to vaccine production in China in one
report, but no details of location)

COLOMBIA
Bogota – pharmaceuticals

EGYPT
Cairo – pharmaceuticals (bought out Amoun Pharmaceuticals)

FRANCE
Herouville - consumer healthcare inc. Gaviscon,  Panadol
(paracetamol), Corsodyl (chhlorhexidine) paroxetine
Evreux – aerosols and powders for inhalers
Mayenne – antibiotics, antiparasitics
(the 2001 annual report mentioned Paris and Nanterre, but these do not
appear in the list of production facilities on the GSK France web
site)

GERMANY 
Dresden –vaccines
Bad Oldesloe - pharmaceuticals

INDIA
Mumbai – pharmaceuticals
Nabha - consumer healthcare
Nashik – formulations
Thane – bulk drugs
Mysore - formulations
Bangalore - formulations
Ankleshwar, Gujarat – ranitidine, griseofulvin, salbutamol and
cephalexin (Agreement on sale of this plant to Glenmark
Pharmaceuticals in November, 2002)

IRELAND
Carrigaline – pharmaceuticals
Dublin - pharmaceuticals
Dungarvan - consumer healthcare

ITALY
Parma – pharmaceuticals
Verona – pharmaceuticals

JAPAN
Takasaki City – pharmaceuticals
Imaichi City - pharmaceuticals

KENYA
Nairobi - pharmaceuticals, consumer healthcare

MALAYSIA
Bangsar Utama – pharmaceuticals

MEXICO
Mexico City – pharmaceuticals
Civac – pharmaceuticals, consumer healthcare

MOROCCO
Rabat - pharmaceuticals

NIGERIA
Lagos – pharmaceuticals (inc. vaccines)

PAKISTAN 
Karachi – pharmaceuticals (inc. antibiotics)

POLAND
Poznan – new, generic and OTC pharmaceuticals

PUERTO RICO
Hato Rey – pharmaceuticals

RUSSIA
Krasnogorsk, near Moscow – Opened in June 2001 - a new vaccine
manufacturing plant 'SB-Biomed' is a joint venture between
GlaxoSmithKline and local Russian partners Biomed and Immunogen -
filling of vaccine ampoules, labelling, packaging and the performance
of quality controls on Engerix B (GSK’s recombinant hepatitis B
vaccine) destined for the Russian market

SAUDI ARABIA
Jeddah – pharmaceuticals (operated by local associate)

SINGAPORE
Singapore – pharmaceuticals
Jurong – pharmaceuticals (fluticasone proprionate, and migraine,
influenza and IBS drugs)

SOUTH AFRICA
Midrand – pharmaceuticals
Johannesburg – consumer healthcare 

SOUTH KOREA
Seoul – pharmaceuticals

SPAIN
Tres Cantos, Madrid – pharmaceuticals
Aranda de Duero, Burgos - pharmaceuticals

THAILAND
Samut Prakan - pharmaceuticals

TURKEY
Gebze, Marmara - pharmaceuticals

UK
Stockley Park – pharmaceuticals
Brentford - pharmaceuticals, consumer healthcare
Greenford – pharmaceuticals
Barnard Castle, Co Durham – pharmaceuticals
Maidenhead  and Slough– parmaceuticals
Beckenham, Kent; 
Crawley, Sussex; 
Coleford, Gloucestershire – Ribena and Lucozade
Dartford, Kent; 
Irvine, Ayrshire; 
Ulverston, Cumbria; 
Ware, Hertfordshire 
Worthing, Sussex.
Speke, Liverpool – rotadisk production facility (due to close by 2004)
Montrose, Scotland (sold to Diosynth, with transfer due in 2003)

USA
Research Triangle Park – pharmaceuticals
Pittsburgh - consumer healthcare
Philadelphia - pharmaceuticals, consumer healthcare
Zebulon, NC - dry powder inhalers. Imitrex, aerosols, tablets and
dermatology products and packaging for all products
Clifton NJ (one reference in a GSK document from 2001: “Production at
these sites would be transferred to GSK's facilities in Maidenhead UK
and Clifton USA”)

VENEZUELA
Caracas - pharmaceuticals, consumer healthcare

Sources

http://www.gsk.com/index.htm
http://www.worldwidevaccines.com/
http://www.new.warsawvoice.pl/view/463
http://www.gsk.com.au/gskinternet/publishing.nsf/Content/12Jul2002-PharmaceuticalInitiativeWelcomed
http://www.gsk.com.au/gskinternet/publishing.nsf/Content/Corp_Contribution
http://www.gsk.com/financial/reports/ar/pdf_excel/report/p136-141.pdf
http://www.newman-machinery.com/labmat11.htm#2
http://www.financialexpress.com/fe/daily/20000117/fco17046.html
http://www.business-standard.com/today/story.asp?Menu=2&story=2403
www.sabb.com.sa/Projects/Web/WebProd.nsf/
IDs/AAAM-4QD2ZS/$File/AlYamamah.pdf
http://news.bbc.co.uk/1/hi/england/1683358.stm
http://www.gsk.com/press_archive/press_06142001.htm
http://www.infectiologia.glaxowellcome.fr/gsk/indus/si.html
http://www.kanto.meti.go.jp/seisaku/databook/sangyo_data_e/foreign_owned/index.html
and numerous confirmatory searches

The answer is indeed as accurate and detailed as I needed it! Thanks.

Over 42,000 employees work at 99 manufacturing sites in 39 countries 
http://www.gsk.com/about/about.htm

How difficult will it be to locate these 99 sites?!

The total has gone up a little.  These figures for manufacturing and
production from the GSK annual report for 2001 might help to target
searches a bit:

Antibiotics supply chain
This is a global organisation with 16 sites, spread across 10
countries.

Other actives supply chain
The active ingredients of non-antibiotic products are produced at ten
sites across the network, located in Australia, India, Ireland,
Singapore, the UK and the USA.

European region
There are 13 sites in the European region spread across seven
countries employing around 8,300 people in total. Between them the
European sites manufacture nearly all of the major pharmaceutical
products marketed globally by GlaxoSmithKline in a wide variety of
finished dosage forms.


North America region 
There are three pharmaceutical sites in the North America region
located in Puerto Rico, Canada and the USA. These sites employ around
1,900 staff.

International region 
The International region comprises 35 manufacturing sites in 19
countries spread across six distinct areas and employs around 8,300
people. There are five sites in Middle East/Africa, 17 sites spread
across the Asia Pacific area, four sites in China, two in Japan and
seven in Latin America.

Vaccines supply chain 
Vaccine production is located principally at Rixensart, Belgium and at
Dresden, Germany. These sites employ around 2,500 staff. Vaccines
production operates as a separate network.


Consumer Healthcare supply chain 
There are 30 Consumer Healthcare manufacturing sites spread across 17
countries, employing around 7,000 staff. The seven sites added as a
result of the January 2001 acquisition of Block Drug have been
incorporated into this supply organisation. The Consumer Healthcare
supply chain is diverse and includes the manufacturing and supply of
OTC medicines, Oral care, Nutritional healthcare and smoking cessation
products.

As part of the network rationalisation plan, production ceased in 2001
at sites in seven countries, including Hungary, Sri Lanka and Taiwan.
The disposal or closure of a further six sites were announced in the
year.

A list of national GSK web sites, which can be more or less helpful,
is available at http://www.gsk.com/worldwide.htm

NB, in addition to Rixensart and Dresden, there is a small facility at
Wavre, Belgium, which produces MMR vaccine.